Imfinzi

Imfinzi Dosage/Direction for Use

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
Dosage/Direction for Use
The recommended dose of IMFINZI depends on the indication as presented in Table 3.
IMFINZI is administered as an intravenous infusion over 1 hour. (See Table 3.)

Click on icon to see table/diagram/image

Dosage Modifications for Adverse Reactions: No dose reductions are recommended. Withhold or discontinue IMFINZI to manage adverse reactions as described in Table 4. (See Table 4.)

Click on icon to see table/diagram/image

Administration: Administer infusion solution intravenously over 60 minutes through an intravenous line containing a sterile, low-protein binding 0.2 or 0.22 micron in-line filter.
Do not co-administer other drugs through the same infusion line.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in